Abstract. Second generation rats depleted in long-chain polyunsaturated ˆ3 fatty acids are currently used as an animal model for the insufficient dietary supply of such fatty acids often prevailing in Western populations. The present study deals mainly with the effects of a novel medium-chain triglyceride: fish oil emulsion (MCT:FO), as compared to a control medium-chain triglyceride:olive oil emulsion (MCT: OO), administered as an intravenous bolus to the ˆ3-depleted rats 60-120 min before sacrifice upon selected biochemical and biophysical variables. The major findings consisted of a severe decrease of the ˆ3 fatty acid content of liver lipids in non-injected ˆ3-depleted rats and its partial correction after injection of the MCT:FO emulsion. The ˆ3-depleted rats also displayed liver steatosis, increased incorporation of long-chain polyunsaturated ˆ6 fatty acids in liver phospholipids and increased activity of liver Δ9-desaturase. As judged from the effects of ouabain upon 86 Rb net uptake by isolated pancreatic islets, the activity of Na + ,K + -ATPase was virtually abolished in the ˆ3-depleted rats. The latter defect was corrected by prior intravenous injection of the MCT:FO emulsion, this coinciding with suppression of the excessive secretory response to a number of insulin secretagogues otherwise observed in the islets of ˆ3-depleted rats injected or not with the MCT:OO emulsion.
Introduction
Second generation rats depleted in long-chain polyunsaturated 3 fatty acids (ˆ3 rats) are currently used as an animal model for the insufficient dietary supply of such fatty acids often prevailing in Western populations (1, 2) . Previous investigations have documented that these ˆ3 rats display several features of metabolic syndrome including visceral obesity (3), liver steatosis (4), insulin resistance (5), hypertension (6) and cardiac hypertrophy (7) . Perturbation of metabolic, ionic and secretory variables were also observed in the pancreatic islets of ˆ3 rats (5, 8, 9) .
A rapid correction of some of these anomalies may be achieved by the bolus intravenous injection of a novel mediumchain triglyceride:fish oil emulsion (MCT:FO). Such a procedure was indeed shown to provoke within 60 min an increase in the phospholipid content of long-chain polyunsaturated ˆ3 fatty acids in platelets and leukocytes of human subjects (10) and livers of both normal and ˆ3-depleted rats (4). The MCT:FO emulsion was designed as a tool for the possible rapid prevention of pathological events resulting from the depletion in ˆ3 fatty acids, for instance cardiac arrhythmia in selected human subjects undergoing urgent anesthesia and/ or surgery.
With this background information in mind, the present study was aimed mainly at investigating the effect of the bolus intravenous injection of MCT:FO to ˆ3 rats, 60-120 min before sacrifice, upon such variables as the liver phospholipid and triglyceride fatty acid pattern, and both the handling of K + and secretion of insulin by pancreatic islets isolated from the ˆ3-depleted rats. Control experiments included the bolus intravenous injection, under the same experimental conditions, of a medium-chain triglyceride:olive oil emulsion (MCT:OO).
Materials and methods
Fed female second generation ˆ3-depleted rats obtained as previously described (5) were compared to fed female normal rats of comparable mean age. The composition of the diets offered to the control and ˆ3-depleted rats was previously described (5) . The ˆ3-depleted rats consisted of three groups of animals (groups 1, 2 and 3) age 8-9, 15-16 and 22-23 weeks, respectively. Some of the ˆ3-depleted rats were injected intravenously 60-120 min before sacrifice with 1.0 ml of either the MCT:FO or MCT:OO emulsion. The composition of these two emulsions was also previously reported (5) .
The plasma D-glucose (11) and insulin (12) concentrations were measured by previously described methods.
For morphological studies, livers were rapidly collected and samples fixed in Bouin's fluid for 24 h. Following fixation, tissues were gradually dehydrated using a series of graded alcohols and embedded in paraffin wax. Five-micron thick histological slides were stained with either hematoxylin and eosin for general aspect or the periodic acid-Schiff's reagent for glycogen identification (13) .
Liver samples were also examined for their phospholipid and triglyceride fatty acid content and pattern, using a previously reported procedure (14) .
Pancreatic islets were isolated by the collagenase method (15) for measurement of their protein (16) and insulin (15) content. Groups of 10 islets each were preincubated for 15-20 min in a non-radioactive medium and then incubated for 10-60 min in the presence of 86 Rb + and used to measure the net uptake of the latter tracer (17) . Likewise, groups of 8 islets each were incubated for 60 min to measure insulin secretion (15) .
All results are presented as mean values (± SEM) together with either the number of separate determinations (n) or degree of freedom (d.f.). The statistical significance of differences between mean values was assessed by use of Student's t-test.
Results
Body weight. At sacrifice the body weight averaged 199.9±2.4 g and 216.8±2.9 g at weeks 8 and 9 (n=20 in both cases, group 1), 261.3±3.9 g and 266.2±3.2 g at weeks 15 and 16 (n=20 in both cases, group 2) and 287.7±4.0 g (n=20; group 3) and 279.6±4.3 g (n=16; group 3) at weeks 22 and 23. Table I , the plasma D-glucose concentration at sacrifice failed to differ significantly in the ˆ3-FO or ˆ3-OO rats, whether in groups 1, 2 or 3. In the ˆ3-FO and ˆ3-OO rats, the mean values recorded 60 and 120 min after injection of the lipid emulsion also failed to differ significantly from one another. The sole significant difference in plasma D-glucose concentration consisted of a decrease (p<0.005) of the overall mean value from 14.07±0.34 mM (n=40) in group 1 to 12.83±0.25 mM (n=40) and 12.76±0.27 mM (n=36) in groups 2 and 3, respectively.
Plasma D-glucose and insulin concentration. As indicated in
A comparable situation prevailed in the case of the plasma insulin concentration (Table II) . Indeed, the sole significant difference in plasma insulin concentration consisted of a decrease (p<0.05 or less) of the overall mean value from 1.06±0.05 ng/ml (n=40) in group 1 to 0.91±0.03 ng/ml (n=40) and 0.94±0.03 ng/ml (n=36) in groups 2 and 3, respectively. -----------------------------------------------------------------------------------------------------Rats  Group 1  Group 2  Group 3  -----------------------------------------------------------------------------------------------------3-NI  not 
All results are expressed as mM. Rats examined 60 or 120 min after intravenous injection of a lipid emulsion.
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All results are expressed as ng/ml. Rats examined 60 or 120 min after intravenous injection of a lipid emulsion.
Liver morphology. No obvious difference was found between control and ˆ3-depleted rats in liver micrographs stained with either hematoxylin and eosin or periodic acid-Shiff (for glycogen identification) and hematoxylin (Fig. 1) .
Liver phospholipid and triglyceride content and fatty acid pattern. In order to assess the effect of the MCT:OO and MCT:FO emulsion upon the phospholipid and triglyceride content and fatty acid pattern, these variables were measured in the livers of the ˆ3 rats injected with one of these emulsions. For the purpose of comparison, the results obtained in the liver of normal rats and ˆ3-NI rats are also presented in Table III .
The total fatty acid content of liver triglycerides was twice higher (p<0.001) in ˆ3 rats (12.2±0.4 mg/g; n=78) than in normal animals (6.5±0.3 mg/g; n=16). Unless otherwise mentioned, there was in this and further comparisons no significant difference between ˆ3-NI, ˆ3-OO and ˆ3-FO rats. The evidence of liver steatosis is reinforced by the unexpected finding of a lower total fatty acid content of liver phospholipids in ˆ3-NI versus control rats (p<0.001).
There were significant correlations between the total amount of fatty acids in liver triglycerides and their content in selected fatty acids. To cite only one example, in the ˆ3-NI rats, the correlation between the total fatty acid content of triglycerides and the relative contribution of C16:0, C18:2ˆ6 and C20:4ˆ6 (n=18 in all cases) amounted respectively to +0.667 (p<0.01), -0.551 (p<0.02) and -0.513 (p<0.05).
In the phospholipids of ˆ3-NI and ˆ3-OO rats, the C18:3ˆ3, C20:5ˆ3, C22:5ˆ3 and C22:6ˆ3 weight percentage was much lower than in control rats. No C18:3ˆ3 and C20:5ˆ3 could indeed be detected in the phospholipids of ˆ3-NI and 3-OO rats, whilst the relative contributions of C22:5ˆ3 and C22:6ˆ3 were ten times lower in these ˆ3-rats than in control animals. Likewise, in the liver triglycerides of ˆ3-NI and ˆ3-OO rats, no long-chain polyunsaturated ˆ3 fatty acids were detected in sharp contrast to the situation found in control rats. Prior intravenous injection of the MCT:FO emulsion 60-120 min before sacrifice augmented, modestly but significantly, the content of liver phospholipids and triglycerides in the long-chain polyunsaturated ˆ3 fatty acids. For instance, in Table III . Fatty acid content and pattern of liver lipids. 
the phospholipids, the weight percentage of these fatty acids was 0.25±0.08% higher (p<0.005) in ˆ3-FO than ˆ3-OO rats. Likewise, significant amounts of C18:3ˆ3, C20:5ˆ3, C22:5ˆ3 and C22:6ˆ3 were often detected in the triglycerides of 3-FO rats, whilst such was never the case in ˆ3-OO rats. When present in detectable amounts in the triglycerides of 3-FO rats, the absolute amount of C18:3ˆ3 averaged 23.8±4.0 μg/g (n=7); that of C20:5ˆ3, 176.9±77.4 μg/g (n=5); that of C22:5ˆ3, 56.0±17.8 μg/g (n=7); and that of C22:6ˆ3, 204.8±81.8 μg/g (n=4). The C22:6ˆ3/C22:5ˆ3 ratio of liver phospholipids was not significantly different in control rats (10.7±0.5; n=16), ˆ3-NI rats (12.3±0.9; n=18), 3-OO rats (10.9±0.7; n=28) and ˆ3-FO rats (11.1±0.8; n=28). Likewise, whenever calculable, the C22:6ˆ3/C22:5ˆ3 ratio of liver triglycerides was not significantly different in control rats (2.57±0.10; n=16) and ˆ3-FO rats (2.31±0.62; n=4).
The weight percentage of long-chain polyunsaturated ˆ6 fatty acids was also vastly different in control and ˆ3 rats. Except in the case of C18:2ˆ6 and C20:2ˆ6, these fatty acids (C18:3ˆ6, C20:3ˆ6, C20:4ˆ6, C22:4ˆ6) indeed displayed a higher contribution (p<0.001) in the phospholipids of ˆ3-NI rats versus control animals. This coincided with a significant increase (p<0.001) of both the C18:3ˆ6/C18:2ˆ6 and C22:4ˆ6/ C20:4ˆ6 ratios in liver phospholipids (Table IV) . The increase in the C18:3ˆ6/C18:2ˆ6 ratio could suggest increased activity of Δ6-desaturase. As judged from the C20:4ˆ6/C20:3ˆ6 ratio, however, the activity of Δ5-desaturase would appear not to be significantly different in the ˆ3-NI rats and control animals. A trend towards an increase in the latter ratio (p<0.06) was only observed when comparing ˆ3 rats injected with a lipid emulsion (53.60±1.85; n=60) to ˆ3-NI rats (46.26±2.62; n=18). In elongase-catalyzed reactions, the product/precursor ratio was either decreased (p<0.001) as judged from the C20:3ˆ6/C18:3ˆ6 ratio or increased (p<0.001) as judged from the C22:4ˆ6/C20:4ˆ6 ratio, when comparing ˆ3-NI to control animals. In terms of the comparison between control and ˆ3-depleted rats, the C18:3ˆ6/C18:2ˆ6, C20:3ˆ6/C18:3ˆ6 and C20:4ˆ6/C20:3ˆ6 ratios displayed a comparable pattern in liver triglycerides as in liver phospholipids. Such was not the case, however, for the C22:4ˆ6/C20:4ˆ6 ratio. Because of the low to undetectable amount of C20:3ˆ6 in liver triglycerides, the C20:4ˆ6/C18:3ˆ6 was also computed in the latter lipids. It was much lower (p<0.001) in ˆ3-NI rats (2.83±0.30; n=18), 3-OO rats (3.27±0.22; n=30) and ˆ3-FO (3.28±0.29; n=30) than in control animals (10.94±0.85; n=16).
The mean value for the weight percentage of the six longchain polyunsaturated ˆ6 fatty acids listed in Table III was always lower in the triglycerides of ˆ3-FO as compared tô 3-OO rats. Pooling all available data, it averaged in the former rats 86.6±3.8% (n=180; p<0.02) of the mean corresponding value found in the latter animals (100.0±3.8%; n=180).
Last, there were also marked differences (p<0.001) in the weight percentage of C16:0, C16:1ˆ7 and C18:1ˆ9 in the liver phospholipids and triglycerides of ˆ3-NI versus control rats (Table III) . In this respect, the most obvious finding consisted of the marked increase in Δ9-desaturase activity in 3-depleted rats as judged from either the C16:1ˆ7/C16:0 or C18:1ˆ9/C18:0 ratio in both phospholipids and triglycerides (Table IV) . As judged from the (C18:0 + C18:1ˆ9)/(C16:0 + C16:1ˆ7) ratio, however, the activity of elongase appeared either increased (p<0.01) or decreased (p<0.005) in the case of triglycerides and phospholipids, respectively (Table IV) .
For the sake of simplicity, the results listed in Tables III  and IV for the ˆ3-NI, ˆ3-OO and ˆ-FO rats refer to the pooled Table IV . Ratio between distinct fatty acids in liver lipids. 
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data collected, in each case, in groups of animals of increasing age (8-9, 15-16 and 22-23 weeks old). It should not be ignored, however, that certain variables under consideration displayed significant age-related changes. To cite only one example, the weight percentage of C22:6ˆ3 in the liver phospholipids of ˆ3-NI and ˆ3-OO rats, progressively increased from 1.24±0.03% in the younger rats to 1.67±0.04% in the middleaged animals and 1.93±0.04% in the older rats (n=16 in all cases). These three values were indeed significantly different (p<0.001) from one another.
Islet protein and insulin content.
In group 1, the islet protein content was not significantly different in ˆ3-OO rats versus either ˆ3-FO or ˆ3-NI rats, with an overall mean value of 1.27±0.07 μg/islet (n=19). Likewise in group 3, the islet protein content was not significantly different (p>0.3 or more) in the ˆ3-OO, ˆ3-NI and ˆ3-FO rats, with an overall mean value of 1.83±0.12 μg/islet (n=18). The latter value was higher (p<0.001), however, than that found in the younger rats of group 1.
In groups 1, 2 and 3, the insulin content of the islets averaged in the ˆ3-FO and ˆ3-NI rats, respectively, 98.1±7.3% (n=17) and 95.1±6.9% (n=23) of the mean corresponding value found within the same series of experiments in ˆ3-OO rats (100.0±9.3%; n=18). The overall mean value for the islet insulin content in group 1 (897±40 μU/islet; n=20) was higher (p<0.001) than that found in either group 2 (451±52 μU/islet; n=19) or group 3 (560±25 μU/islet; n=19), which failed to differ significantly from one another.
86 Rb net uptake. Two major differences were observed between the islets from ˆ3-OO and ˆ3-FO rats in terms of 86 Rb handling (Table V) .
First, after only 10-min incubation, i.e. when the net uptake of 86 Rb informs mainly on the rate of K + entry into the islet cells, the values for such an uptake found in the presence of ouabain, expressed relative to the mean corresponding value recorded within the same experiment(s) in the absence of the cardiac glycoside, averaged in the ˆ3-OO rats 88.4±2.5% (n=48), as distinct (p<0.01) from only 77.6±3.1% (n=43) in the ˆ3-FO rats. In both cases, the ouabain-induced decrease in 86 Rb net uptake achieved statistical significance, amounting to 11.6±4.2% (d.f.=94; p<0.01) in ˆ3-OO rats and 22.4±4.2% (d.f.=88; p<0.001) in ˆ3-FO rats. These findings suggest that the activity of the Na,K-ATPase, as judged from the ouabaininduced decrease in 86 Rb net uptake, was approximately twice higher in ˆ3-FO rats than in ˆ3-OO rats.
Second, when the 86 Rb net uptake found after 10-min incubation was expressed relative to the mean corresponding value found within the same experiment(s) after 60-min incubation, such a ratio averaged, in the absence of ouabain, 52.1±2.1% (n=48) in ˆ3-OO rats, as compared (p<0.02) to 44.3±2.3% (n=47) in ˆ3-FO rats (Table I ). In the presence of ouabain, the mean value for such a ratio was also higher (p<0.001) in ˆ3-OO rats (61.2±2.2%; n=48) than in ˆ3-FO rats (47.5±2.5%; n=43). Moreover, the cardiac glycoside augmented significantly (p<0.005) such a ratio in ˆ3-OO rats, whilst failing to do so (p>0.3) in ˆ3-FO rats. These findings indicate that the fractional turnover rate of the islet K + pool is lower in ˆ3-FO rats than in ˆ3-OO rats, being further increased by ouabain in the latter animals. Indeed, as derived from the equation U = Umax (1 -e kt ), in which U and Umax refer to the net uptake of 86 Rb at time t and at isotopic equilibrium, respectively, and K to the fractional outflow rate (18) , the latter variable expressed per min -1 was close to 0.072 and 0.056 in the islets prepared from ˆ3-OO and ˆ3-FO rats, respectively, and incubated in the absence of ouabain, and 0.094 and 0.062 in the islets from the same animals incubated in the presence of the cardiac glycoside.
Despite such differences in fractional outflow rate, the estimated values for Umax, as also derived from the mean absolute value for 86 Rb net uptake at min 60 remained not significantly different in ˆ3-OO and ˆ3-FO rats, whether in the absence or presence of ouabain, with overall mean values Table V. 86 Rb net uptake by islets. Ouabain  Nil  50 μM  Nil  50 
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of 213.1±6.5 pmol/islet (n=96) and 156.8±4.5 pmol/islet (n=98) in the absence and presence of the cardiac glycoside, respectively.
Nevertheless, when making allowance for the difference in 86 Rb fractional outflow rate, the estimated inflow-outflow rate at isotopic equilibrium remained significantly lower (p<0.005 or less) in ˆ3-FO rats than ˆ3-OO rats, whether in the absence of ouabain (12.2±0.6 versus 14.9±0.5 pmol/islet per min) or in its presence (9.9±0.4 versus 14.5±0.5 pmol/ islet per min). Most importantly, these data document that ouabain significantly decreased (p<0.005) 86 Rb + inflow in the islets from ˆ3-FO rats, whilst failing to do so (p>0.5) in the islets from ˆ3-OO rats.
The present measurements of 86 Rb net uptake thus confirm that the activity of the Na + ,K + -ATPase mediating part of 86 Rb influx into the islet cells is significantly higher in ˆ3-FO rats than in ˆ3-OO rats (9) . Despite such a situation, the net uptake of 86 Rb after 10-min incubation was somewhat lower in ˆ3-FO than ˆ3-OO rats, averaging in the former animals 85.3±4.2% (n=47; p<0.01) of the mean corresponding values found, at the same age, in ˆ3-OO rats (100.0±3.4%; n=48). This apparently implies that the prior administration of the MCT:FO emulsion decreased the influx of 86 Rb by an ouabain-resistant modality. After 10-min incubation, the net uptake of 86 Rb + was not only lower in absolute terms in ˆ3-FO than ˆ3-OO rats. Even when expressed relative to the corresponding value found within the same experiment(s) after 60-min incubation, it remained significantly lower in ˆ3-FO than ˆ3-OO rats. This finding is again consistent with the postulated inhibition after intravenous injection of the MCT:FO emulsion of the ouabain-resistant modality of 86 Rb inflow into islet cells. In turn, the lower fractional turnover rate of 86 Rb + found in ˆ3-FO versus ˆ3-OO rats is reminiscent of the modest improvement of D-glucose metabolism found in the islets of the former, as distinct from latter animals (5). In islets from normal rats, the fractional outflow rate of 86 Rb + is indeed decreased at increasing concentrations of extracellular D-glucose (19) . Last, when the true inflow rate of 86 Rb was computed from the fractional turnover rate and steady-state value for 86 Rb net uptake at isotopic equilibrium, it became evident that ouabain decreases by approximately 20% the inflow of 86 Rb into the islet cells of ˆ3-FO rats, whilst failing to affect such an inflow in the islets of ˆ3-OO rats.
Secretory data. The release of insulin evoked by 8.3 mM Dglucose over 60-min incubation was significantly higher in the islets from ˆ3-FO rats than ˆ3-OO rats (Table VI) . When compared within each set of experiments conducted in animals of the same age, the output of insulin averaged, in the ˆ3-FO rats, 138.6±4.7% (n=64; p<0.001) of that recorded in thê 3-OO rats (100.0±4.8%; n=71). When the release of insulin recorded in the concomitant presence of D-glucose (8.3 mM) and another secretagogue was expressed relative to the control value measured within the same experiment in the sole presence of the hexose, all agents listed in Table VI were found to augment significantly (p<0.01 or less) glucose-induced insulin secretion in the islets of ˆ3-OO rats, except ouabain which decreased (p<0.02) the secretory response to the hexose. In the ˆ3-FO rats, however, glibenclamide failed to augment significantly insulin secretion evoked by D-glucose and carbamylcholine even impaired (p<0.005) the insulinotropic action of the sugar.
As judged from the ratio between the results obtained in each experiment in the presence versus absence of given secretagogues, the mean relative magnitude of the secretory response was always higher in the ˆ3-OO rats than in thê 3-FO rats (Table VI ; relative values expressed in % of control). Moreover, when the results so obtained in the ˆ3-OO and ˆ3-FO rats were compared within each set of experiments conducted in animals of the same age (Table VI; right columns), the latter difference achieved statistical significance (p<0.05 or less) with all tested secretagogues. In such a respect, the least marked difference between ˆ3-OO and ˆ3-FO rats, both in quantitative and statistical terms, referred to the islets exposed to cytochalasin B.
Discussion
The present study extends prior observations also conducted in second generation ˆ3-depleted rats and dealing with such --------------------------------------------------------------------------------------------------- -
items as plasma D-glucose and insulin concentration (5), liver phospholipid and triglyceride fatty acid content and pattern (4), pancreatic islet protein and insulin content (5), and both 86 Rb net uptake (9) and insulin secretion (5, 8) by isolated islets. In these respects, emphasis is here placed on the comparison between ˆ3-depleted rats injected 60-120 min before sacrifice with either MCT:FO or MCT:OO. The major findings can be described as follows. First, the present study documents an age-related decrease of both plasma D-glucose and insulin concentrations in the ˆ3-depleted rats, this coinciding with a progressive increase in the weight percentage of C22:6ˆ3 in the liver phospholipids. These results are compatible with the modulation of insulin resistance, previously documented in ˆ3-depleted rats (5), by the relative content of long-chain polyunsaturated ˆ3 fatty acids in phospholipids. In this respect, it should be underlined that the insulin content of isolated islets was also lower in older ˆ3-depleted rats, despite an age-related increase of the islet protein content.
Second, the measurements of liver phospholipid and triglyceride total fatty acid content confirm the presence of hepatic steatosis in the ˆ3-depleted rats, this coinciding with an unexpected decrease in liver phospholipid total fatty acid content. In addition to documenting the depletion of ˆ3 fatty acids in the liver phospholipids and triglycerides of ˆ3-NI rats and the partial correction of such a defect in ˆ3-FO rats, the fatty acid pattern of liver in ˆ3-NI rats was characterized by higher contributions of C18:3ˆ6, C20:3ˆ6, C20:4ˆ6 and C22:4ˆ6 than those recorded in control animals. The generation of C18:3ˆ6 from C18:2ˆ6 and that of C22:4ˆ6 from C20:4ˆ6 also appeared more efficient in ˆ3-NI rats than in control animals, as judged from the phospholipid ratio between relevant fatty acids.
Third, the activity of Δ9-desaturase was apparently also increased in ˆ3-NI rats (or other groups of ˆ3-depleted animals), as judged from the liver phospholipid or triglyceride C16:0/C16:1ˆ7 and C18:0/C18:1ˆ9 ratios.
Nevertheless, no obvious alteration of the general aspect or glycogen content of the liver was observed at the histological level.
The present results also confirm that ouabain significantly decreases 86 Rb + inflow in the islets from ˆ3-FO rats, whilst failing to do so in the islets from ˆ3-OO rats. The latter finding is consistent with prior observations made in the islets of ˆ3-NI or ˆ3-OO rats and indicating a low activity of Na + ,K + -ATPase in such islets, as judged by the effect of ouabain upon 86 Rb + net uptake (9) . In both this prior and the present study, the intravenous injection of the MCT:FO emulsion restored a sizeable activity of the latter enzyme.
Last, the secretory data collected in the present study (Table VI) again extend prior observations (5, 8) indicating that, relative to the release of insulin recorded in the sole presence of 8.3 mM D-glucose, that found in the concomitant presence of other insulin secretagogues is significantly lower in the islets from ˆ3-FO rats than in those from ˆ3-OO rats. A comparable situation is found when comparing islets from control rats to those obtained from ˆ3-NI rats (5, 8) .
In conclusion, therefore, the present study reinforces the knowledge that second generation ˆ3-depleted rats, with low content of long-chain polyunsaturated ˆ3 fatty acids in tissue lipids, display liver steatosis, facilitated generation and incorporation into phospholipids of long-chain polyunsaturated 6 fatty acids, increased activity of Δ9-desaturase, impaired activity of ouabain-sensitive Na + ,K + -ATPase in pancreatic islets and increased responsiveness to a number of insulin secretagogues in isolated islets exposed to a physiological concentration of D-glucose. Moreover, the present results confirm that the latter two anomalies are corrected within 60-120 min by the prior injection of the long-chain polyunsaturated ˆ3 fatty acid-rich MCT:FO emulsion.
